Leveraging CD19CAR T cells early in the treatment of older patients with B-ALL: are we there yet?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Leveraging CD19CAR T cells early in the treatment of older patients with B-ALL: are we there yet?

Published:2024-01-05 Issue:4 Volume:65 Page:440-448
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Aldoss Ibrahim¹²³,Clark Mary Caroline¹⁴,Wang Xiuli¹⁵,Forman Stephen Joel¹³⁵

Affiliation:

1. Hematological Malignancies Research Institute, Duarte, CA, USA

2. Gehr Family Center for Leukemia Research, Duarte, CA, USA

3. Department of Hematology/Hematopoietic Cell Transplantation, Duarte, CA, USA

4. Department of Clinical and Translational Project Development, Duarte, CA, USA

5. T Cell Therapeutic Research Laboratories, City of Hope, Duarte, CA, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2298712

Reference70 articles.

1. SEER: surveilance EaERP. Cancer StatFacts: acute lymphocytic leukemia (ALL). 2023. https://seer.cancer.gov/statfacts/html/alyl.html

2. Acute lymphoblastic leukemia: A population‐based study of outcome in the U nited S tates based on the surveillance, epidemiology, and end results ( SEER ) database, 1980 – 2017

3. Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis

4. The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia

5. High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in Adults

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP